GLP-1 drug tirzepatide may boost calorie-burning brown fat

(NewsNation) — The GLP-1 medication tirzepatide may change how the body uses energy, according to new research.

The study, presented at the Endocrine Society’s ENDO 2026 meeting, found tirzepatide activates brown adipose tissue. The drug is also sold under the brand names Zepbound and Mounjaro.

“In the TABFAT trial, we asked a different question: Beyond eating less, does tirzepatide also change how the body burns energy — specifically through brown adipose tissue, a metabolically active type of fat that produces heat and consumes calories?” said Dr. Rok Herman of the University Medical Centre Ljubljana in........

© The Hill